{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:08:04Z","timestamp":1791965284729,"version":"4.3.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12185-019-02661-7","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T22:51:58Z","timestamp":1557960718000},"page":"381-384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Significance of biopsy with ERCP for diagnosis of bile duct invasion of DLBCL"],"prefix":"10.1007","volume":"110","author":[{"given":"Yusuke","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoka","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naminatsu","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousuke","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Taoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Shinozaki-Ushiku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4034-2422","authenticated-orcid":false,"given":"Mineo","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,15]]},"reference":[{"key":"2661_CR1","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMra0807082","volume":"362","author":"G Lenz","year":"2010","unstructured":"Lenz G, Staudt LM. Aggressive lymphomas. N Engl J Med. 2010;362:1417\u201329.","journal-title":"N Engl J Med"},{"key":"2661_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","unstructured":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med. 1993;329:987\u201394.","journal-title":"N Engl J Med"},{"key":"2661_CR3","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s10620-007-9786-4","volume":"52","author":"B Odemi\u015f","year":"2007","unstructured":"Odemi\u015f B, Parlak E, Ba\u015far O, Y\u00fcksel O, Sahin B. Biliary tract obstruction secondary to malignant lymphoma: experience at a referral center. Dig Dis Sci. 2007;52:2323\u201332.","journal-title":"Dig Dis Sci"},{"key":"2661_CR4","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1182\/blood-2012-06-435842","volume":"121","author":"H Horn","year":"2013","unstructured":"Horn H, Ziepert M, Becher C, Barth TF, Bernd HW, Feller AC, et al. MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. Blood. 2013;121:2253\u201363.","journal-title":"Blood"},{"key":"2661_CR5","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/1097-0142(19950401)75:7<1669::AID-CNCR2820750718>3.0.CO;2-3","volume":"75","author":"P Fidias","year":"1995","unstructured":"Fidias P, Carey RW, Grossbard ML. Non-Hodgkin's lymphoma presenting with biliary tract obstruction. A discussion of seven patients and a review of the literature. Cancer. 1995;75:1669\u2013777.","journal-title":"Cancer"},{"key":"2661_CR6","doi-asserted-by":"publisher","first-page":"259642","DOI":"10.1155\/2013\/259642","volume":"2013","author":"D Chaudhari","year":"2013","unstructured":"Chaudhari D, Khan S, Saleem A, Taylor T, Reddy C, Borthwick T, et al. Obstructive jaundice as an initial manifestation of non-Hodgkin lymphoma: treatment dilemma and high mortality. Case Rep Med. 2013;2013:259642.","journal-title":"Case Rep Med"},{"key":"2661_CR7","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00277-015-2390-3","volume":"94","author":"XW Bi","year":"2015","unstructured":"Bi XW, Zhang WW, Li ZM, Huang JJ, Xia Y, Sun P, et al. The extent of local tumor invasion predicts prognosis in stage IE nasal natural killer\/T-cell lymphoma: a novel T staging system for risk stratification. Ann Hematol. 2015;94:1515\u201324.","journal-title":"Ann Hematol"},{"key":"2661_CR8","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/sj.leu.2401487","volume":"13","author":"S Harada","year":"1999","unstructured":"Harada S, Suzuki R, Uehira K, Yatabe Y, Kagami Y, Ogura M, et al. Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5\u2212 with CD10+ groups may constitute clinically relevant subtypes. Leukemia. 1999;13:1441\u20137.","journal-title":"Leukemia"},{"key":"2661_CR9","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1349-7006.2006.00267.x","volume":"97","author":"M Suguro","year":"2006","unstructured":"Suguro M, Tagawa H, Kagami Y, Okamoto M, Ohshima K, Shiku H, et al. Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup: development of a CD5 signature. Cancer Sci. 2006;97:868\u201374.","journal-title":"Cancer Sci"},{"key":"2661_CR10","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1093\/annonc\/mdq057","volume":"21","author":"N Niitsu","year":"2010","unstructured":"Niitsu N, Okamoto M, Tamaru JI, Yoshino T, Nakamura N, Nakamura S, et al. Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma. Ann Oncol. 2010;21:2069\u201374.","journal-title":"Ann Oncol"},{"key":"2661_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2165\/00002018-200629060-00004","volume":"29","author":"L Tchambaz","year":"2006","unstructured":"Tchambaz L, Schlatter C, Jakob M, Kr\u00e4henb\u00fchl A, Wolf P, Kr\u00e4henb\u00fchl S. Dose adaptation of antineoplastic drugs in patients with liver disease. Drug Saf. 2006;29:509\u201322.","journal-title":"Drug Saf"},{"key":"2661_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/cpt1977222234","volume":"22","author":"CE Riggs Jr","year":"1977","unstructured":"Riggs CE Jr, Benjamin RS, Serpick AA, Bachur NR. Bilary disposition of adriamycin. Clin Pharmacol Ther. 1977;22:234\u201341.","journal-title":"Clin Pharmacol Ther"},{"key":"2661_CR13","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1007\/s10620-010-1310-6","volume":"55","author":"WA Ross","year":"2010","unstructured":"Ross WA, Egwim CI, Wallace MJ, Wang M, Madoff DC, Lee JH. Outcomes in lymphoma patients with obstructive jaundice: a cancer center experience. Dig Dis Sci. 2010;55:3271\u20137.","journal-title":"Dig Dis Sci"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02661-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-019-02661-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02661-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T23:46:42Z","timestamp":1589413602000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-019-02661-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["2661"],"URL":"https:\/\/doi.org\/10.1007\/s12185-019-02661-7","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,15]]},"assertion":[{"value":"4 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}